MEDIPOST has submitted an investigational new drug (IND) amendment to the US Food and Drug Administration (FDA) to initiate a ...

Please provide your email address to receive an email when new articles are posted on . Umbilical cord-derived PRP reduced VAS pain scores more than adipose tissue-derived mesenchymal stem cells after ...

Compared with an injection of saline placebo, a single intra-articular injection of autologous adipose-derived mesenchymal stromal cells showed no significant improvement in pain or function scores in ...

Beyond the Bone Marrow İSTANBUL, BEşIKTAş, TURKEY, February 3, 2026 /EINPresswire.com/ -- How Stem Cell Transplantation ...

MEDIPOST's investigational therapy is an umbilical cord blood-derived allogeneic mesenchymal stem cell therapy designed to treat symptomatic cartilage defects in patients with knee osteoarthritis.

More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, with symptoms (such as pain, stiffness and reduced movement) affecting ...

Stem cell therapy in knee medicine is evolving and potentially positive as a non-invasive treatment for osteoarthritis or cartilage injuries. When you consider the number of patients who are suffering ...

It’s a joint venture. Longevity enthusiasts are flying around the world and spending thousands of dollars to have stem cells injected into their ailing knees. Bryan Johnson, the businessman famed for ...

Samuel Whittle is supported by an Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network Practitioner Fellowship and by a grant from The Hospital Research Foundation Group. Dr ...

More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, with symptoms (such as pain, stiffness and reduced movement) affecting ...